Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
37.5M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
95.3K
-
Shares change
-
+83.3K
-
Total reported value, excl. options
-
$176K
-
Value change
-
+$154K
-
Number of buys
-
6
-
Price
-
$1.85
Significant Holders of OKYO Pharma Ltd - Common (OKYO) as of Q3 2023
7 filings reported holding OKYO - OKYO Pharma Ltd - Common as of Q3 2023.
OKYO Pharma Ltd - Common (OKYO) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 95.3K shares
of 37.5M outstanding shares and own 0.25% of the company stock.
Largest 7 shareholders include BARCLAYS PLC (25K shares), RENAISSANCE TECHNOLOGIES LLC (16.3K shares), CITADEL ADVISORS LLC (15.9K shares), MORGAN STANLEY (13.8K shares), GEODE CAPITAL MANAGEMENT, LLC (12.1K shares), HSBC HOLDINGS PLC (11.9K shares), and UBS Group AG (95 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.